Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The excitatory amino acid receptor signaling pathway refers to the cellular processes initiated by the binding of excitatory amino acids—most notably glutamate—to their respective receptors in the central nervous system (CNS). This pathway is fundamental for fast synaptic transmission, neural plasticity, and overall brain function. Dysregulation of this pathway is implicated in various neurological disorders. Key receptors include ionotropic (NMDA, AMPA, Kainate) and metabotropic glutamate receptors (mGluRs). The pathway plays essential roles in learning, memory, and neuronal network activity but can lead to excitotoxicity and neurodegeneration if dysregulated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Excitatory Amino Acid Receptor Signaling Pathway.